AU2459297A - Method of preparing phosphodiesterase iv inhibitors - Google Patents

Method of preparing phosphodiesterase iv inhibitors

Info

Publication number
AU2459297A
AU2459297A AU24592/97A AU2459297A AU2459297A AU 2459297 A AU2459297 A AU 2459297A AU 24592/97 A AU24592/97 A AU 24592/97A AU 2459297 A AU2459297 A AU 2459297A AU 2459297 A AU2459297 A AU 2459297A
Authority
AU
Australia
Prior art keywords
inhibitors
phosphodiesterase
preparing
preparing phosphodiesterase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU24592/97A
Inventor
Ioannis Houpis
Audrey Molina
Ralph P. Volante
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9612083.7A external-priority patent/GB9612083D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU2459297A publication Critical patent/AU2459297A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • C07D213/34—Sulfur atoms to which a second hetero atom is attached
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU24592/97A 1996-04-17 1997-04-14 Method of preparing phosphodiesterase iv inhibitors Abandoned AU2459297A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1568796P 1996-04-17 1996-04-17
US60015687 1996-04-17
GBGB9612083.7A GB9612083D0 (en) 1996-06-10 1996-06-10 Method of preparing phosphodiesterase IV inhibitors
GB9612083 1996-06-10
PCT/US1997/006131 WO1997038976A1 (en) 1996-04-17 1997-04-14 Method of preparing phosphodiesterase iv inhibitors

Publications (1)

Publication Number Publication Date
AU2459297A true AU2459297A (en) 1997-11-07

Family

ID=26309476

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24592/97A Abandoned AU2459297A (en) 1996-04-17 1997-04-14 Method of preparing phosphodiesterase iv inhibitors

Country Status (10)

Country Link
EP (1) EP0898564A1 (en)
CN (1) CN1216532A (en)
AR (1) AR006550A1 (en)
AU (1) AU2459297A (en)
BR (1) BR9708684A (en)
CZ (1) CZ333298A3 (en)
EA (1) EA000877B1 (en)
SK (1) SK143198A3 (en)
TW (1) TW426669B (en)
WO (1) WO1997038976A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69712631D1 (en) * 1996-09-17 2002-06-20 Merck & Co Inc METHOD FOR PRODUCING PHOSPHODIESTERASE IV INHIBITORS
TW508353B (en) * 1996-09-17 2002-11-01 Merck & Co Inc Method of preparing phosphodiesterase IV inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW263495B (en) * 1992-12-23 1995-11-21 Celltech Ltd
GB9326173D0 (en) * 1993-12-22 1994-02-23 Celltech Ltd Chemical compounds and process

Also Published As

Publication number Publication date
AR006550A1 (en) 1999-09-08
EA199800931A1 (en) 1999-04-29
EA000877B1 (en) 2000-06-26
CN1216532A (en) 1999-05-12
WO1997038976A1 (en) 1997-10-23
BR9708684A (en) 1999-08-03
SK143198A3 (en) 1999-06-11
EP0898564A1 (en) 1999-03-03
CZ333298A3 (en) 1999-03-17
TW426669B (en) 2001-03-21

Similar Documents

Publication Publication Date Title
AU2913701A (en) System and method for facilitating selection of benefits
AU6419296A (en) Cyclic gmp-specific phosphodiesterase inhibitors
AU4594497A (en) Set of tools for use un urethropexy procedures
AU4756696A (en) Compounds for and method of inhibiting phosphodiesterase iv
AU2108997A (en) Adhesion inhibitors, preparation comprising them and method for producing them
AU2542397A (en) Method of preparing electrodes
AU7570996A (en) Quinoline derivatives as type iv phosphodiesterase inhibitors
AUPO307196A0 (en) Method of controlled blasting
AU3005297A (en) Method of locating hydrophones
AU5317398A (en) Method for preparing cyclopropylamines
AU3075595A (en) Anti-helicobacter heterocyclic derivatives of azolones
AU2277597A (en) New inhibitors of sh2-mediated processes
AU5737498A (en) Method for the preparation of alpha-bromo-lactam derivatives
AU4325397A (en) Method of omeprazole preparation
AU5888198A (en) Process for determination of nitrogen
AU1710095A (en) Method for isolating of wheyproteins
AU2459297A (en) Method of preparing phosphodiesterase iv inhibitors
AU9526198A (en) Method for inhibiting eukaryotic protein kinases
AU9526298A (en) Method for inhibiting eukaryotic protein kinases
GB9612083D0 (en) Method of preparing phosphodiesterase IV inhibitors
GR3034674T3 (en) Method of preparing phosphodiesterase iv inhibitors
GB9625819D0 (en) Method of preparing phosphodiesterase IV inhibitors
AUPO421596A0 (en) Method of maintaining turf
AU7222596A (en) Method of decoration
AU5346298A (en) Method for the preparation of melamine